+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cardiovascular Inflammation Drug"

Cardiovascular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players - Product Thumbnail Image

Cardiovascular Inflammation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • Report
  • May 2022
  • 76 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

The Cardiovascular Inflammation Drug market is a subset of the larger Cardiovascular Drugs market. It focuses on drugs that are used to treat inflammation of the cardiovascular system, such as atherosclerosis, coronary artery disease, and congestive heart failure. These drugs are typically used to reduce inflammation, improve blood flow, and reduce the risk of heart attack and stroke. Commonly used drugs in this market include statins, ACE inhibitors, and anti-inflammatory drugs. The Cardiovascular Inflammation Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in this market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. Show Less Read more